Novavax
NVAX
#5458
Rank
$1.50 B
Marketcap
$9.13
Share price
-3.89%
Change (1 day)
42.43%
Change (1 year)

Novavax (NVAX) - Net assets

Net assets on the balance sheet as of March 2026 : -$0.15 Billion USD

According to Novavax's latest financial reports the company has -$0.15 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novavax - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-$0.13 Billion-79.52%
2024-12-31$-$0.63 Billion-12.98%
2023-12-31$-$0.72 Billion13.07%
2022-12-31$-$0.64 Billion80.3%
2021-12-31$-$0.36 Billion-156.07%
2020-12-31$$0.62 B-437.18%
2019-12-31$-$0.19 Billion10.77%
2018-12-31$-$0.17 Billion65.08%
2017-12-31$-$0.11 Billion1734.33%
2016-12-31$-$5.55 Million-101.89%
2015-12-31$$0.29 B27.46%
2014-12-31$$0.22 B12.98%
2013-12-31$$0.20 B153.28%
2012-12-31$$80.24 M49.01%
2011-12-31$$53.84 M-8.81%
2010-12-31$$59.05 M-15.58%
2009-12-31$$69.95 M53.78%
2008-12-31$$45.48 M-27.87%
2007-12-31$$63.06 M-32.91%
2006-12-31$$94 M89.32%
2005-12-31$$49.65 M49.19%
2004-12-31$$33.28 M-7.41%
2003-12-31$$35.94 M345.24%
2002-12-31$$8.07 M-70.64%
2001-12-31$$27.49 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
$38.92 B-26,990.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$90.40 B-62,550.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$47.38 B-32,832.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
$23.07 B-16,038.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
$1.50 B-1,139.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$0.45 B-415.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-$0.29 Billion 94.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
$7.17 M-104.96%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-$0.56 Billion 282.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.58 B-502.38%๐Ÿ‡บ๐Ÿ‡ธ USA